Midkine and CA9 Are Potential Cancer Stem Cell Biomarkers in Triple‐Negative Breast Tumours
Introduction There is no specific therapy for triple‐negative breast cancer (TNBC), and the recurrence rate is high. Cancer stem cells (CSCs) play an important role in cancer chemoresistance and metastasis, but there is no consensus marker in this type of cancer. The aim of this study was to identify CSC biomarkers in...